Cargando…

Lupus erythematosus tumidus: clinical perspectives

Lupus erythematosus tumidus (LET) is an uncommon and photosensitive inflammatory skin disorder which is characterised by erythematous urticarial plaques. In the last 20 years, extensive research on clinical and histological aspects of the disease have led to a better characterization of this nosolog...

Descripción completa

Detalles Bibliográficos
Autores principales: Patsinakidis, Nikolaos, Kautz, Ocko, Gibbs, Bernhard F, Raap, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778445/
https://www.ncbi.nlm.nih.gov/pubmed/31632119
http://dx.doi.org/10.2147/CCID.S166723
_version_ 1783456766410883072
author Patsinakidis, Nikolaos
Kautz, Ocko
Gibbs, Bernhard F
Raap, Ulrike
author_facet Patsinakidis, Nikolaos
Kautz, Ocko
Gibbs, Bernhard F
Raap, Ulrike
author_sort Patsinakidis, Nikolaos
collection PubMed
description Lupus erythematosus tumidus (LET) is an uncommon and photosensitive inflammatory skin disorder which is characterised by erythematous urticarial plaques. In the last 20 years, extensive research on clinical and histological aspects of the disease have led to a better characterization of this nosological entity and to differentiate it from other similar or related diseases. Today, LET is considered as a separate subtype of cutaneous lupus erythematosus (CLE) with a benign, intermittent clinical course (intermittent CLE, ICLE) and only rarely associated with systemic lupus erythematosus (SLE).
format Online
Article
Text
id pubmed-6778445
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-67784452019-10-18 Lupus erythematosus tumidus: clinical perspectives Patsinakidis, Nikolaos Kautz, Ocko Gibbs, Bernhard F Raap, Ulrike Clin Cosmet Investig Dermatol Review Lupus erythematosus tumidus (LET) is an uncommon and photosensitive inflammatory skin disorder which is characterised by erythematous urticarial plaques. In the last 20 years, extensive research on clinical and histological aspects of the disease have led to a better characterization of this nosological entity and to differentiate it from other similar or related diseases. Today, LET is considered as a separate subtype of cutaneous lupus erythematosus (CLE) with a benign, intermittent clinical course (intermittent CLE, ICLE) and only rarely associated with systemic lupus erythematosus (SLE). Dove 2019-10-01 /pmc/articles/PMC6778445/ /pubmed/31632119 http://dx.doi.org/10.2147/CCID.S166723 Text en © 2019 Patsinakidis et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Patsinakidis, Nikolaos
Kautz, Ocko
Gibbs, Bernhard F
Raap, Ulrike
Lupus erythematosus tumidus: clinical perspectives
title Lupus erythematosus tumidus: clinical perspectives
title_full Lupus erythematosus tumidus: clinical perspectives
title_fullStr Lupus erythematosus tumidus: clinical perspectives
title_full_unstemmed Lupus erythematosus tumidus: clinical perspectives
title_short Lupus erythematosus tumidus: clinical perspectives
title_sort lupus erythematosus tumidus: clinical perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778445/
https://www.ncbi.nlm.nih.gov/pubmed/31632119
http://dx.doi.org/10.2147/CCID.S166723
work_keys_str_mv AT patsinakidisnikolaos lupuserythematosustumidusclinicalperspectives
AT kautzocko lupuserythematosustumidusclinicalperspectives
AT gibbsbernhardf lupuserythematosustumidusclinicalperspectives
AT raapulrike lupuserythematosustumidusclinicalperspectives